|
|
Article: CPEX Pharmaceuticals and Serenity Pharmaceuticals Announce Collaboration on Drug Candidate for Urology Indication.
- Article from:
- Business Wire
- Article date:
- August 4, 2008
|
Copyright informationCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Serenity Files IND for Intranasal Drug Employing CPEX's Delivery Platform
EXETER, N.H. -- CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) and privately held Serenity Pharmaceuticals today announced that they are collaborating on an intranasal drug candidate for a urology indication. New York-based Serenity's drug candidate will be delivered using CPEX's patented drug delivery technology. Serenity believes the drug targets a potential worldwide market of $2 - $3 billion.
The collaboration between Serenity and CPEX began in September 2007 as a feasibility study and advanced to the signing of a development and license agreement in February 2008. Serenity has filed an ...